What's Going On With Acurx Pharmaceuticals Inc Stock Today?
Portfolio Pulse from Erica Kollmann
Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) shares are trading higher, despite being down more than 30% over the last month. The company last released news at the beginning of October, announcing positive results from a Phase 2b clinical trial of its lead antibiotic candidate, ibezapolstat. Shares of ACXP are moving higher on heavy trading volume, with more than 1.4 million shares traded in the session, far exceeding the stock's 100-day average of less than 544 thousand shares.
October 18, 2023 | 4:10 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Acurx Pharmaceuticals shares are trading higher on heavy volume, despite a 30% drop over the last month. The company recently announced positive results from a Phase 2b clinical trial of its lead antibiotic candidate, ibezapolstat.
The positive results from the Phase 2b clinical trial of Acurx's lead antibiotic candidate, ibezapolstat, have likely contributed to the increased trading volume and higher share price. However, the stock is still down more than 30% over the last month, indicating that there may be other factors at play affecting the stock's performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100